Resultados de procura - Walter Taal

  • Mostrando 1 - 16 Resultados de 16
Limitar resultados
  1. 1
    Chemotherapy in glioma

    Chemotherapy in glioma por Walter Taal, Jacoline E. C. Bromberg, Martin J. van den Bent

    Publicado 2015
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  2. 2
    Endothelial CD276 (B7-H3) expression is increased in human malignancies and distinguishes between normal and tumour-derived circulating endothelial cells

    Endothelial CD276 (B7-H3) expression is increased in human malignancies and distinguishes between normal and tumour-derived circulating endothelial cells por Jaco Kraan, Peterhans van den Broek, Cornelis Verhoef, Dirk J. Grünhagen, Walter Taal, Jan W. Gratama, Stefan Sleijfer

    Publicado 2014
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  3. 3
    Incidence of pseudoprogression in low-grade gliomas treated with radiotherapy

    Incidence of pseudoprogression in low-grade gliomas treated with radiotherapy por Sophie E. van West, Hein G. de Bruin, Bart van de Langerijt, Annemarie T. Swaak‐Kragten, Martin J. van den Bent, Walter Taal

    Publicado 2016
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  4. 4
    Worries and needs of adults and parents of adults with neurofibromatosis type 1

    Worries and needs of adults and parents of adults with neurofibromatosis type 1 por André B. Rietman, Hanneke van Helden, Pauline Helene Both, Walter Taal, Jeroen S. Legerstee, AnneLoes van Staa, Henriëtte A. Moll, Rianne Oostenbrink, Agnies M. van Eeghen

    Publicado 2018
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  5. 5
    Withdrawal of antiepileptic drugs in patients with low grade and anaplastic glioma after long-term seizure freedom: a prospective observational study

    Withdrawal of antiepileptic drugs in patients with low grade and anaplastic glioma after long-term seizure freedom: a prospective observational study por Melissa Kerkhof, Johan A F Koekkoek, Maaike J. Vos, Martin J. van den Bent, Walter Taal, Tjeerd J. Postma, Jacoline E. C. Bromberg, Mathilde C.M. Kouwenhoven, Linda Dirven, Jaap C. Reijneveld, Martin Taphoorn

    Publicado 2019
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  6. 6
    Comparison of 2D (RANO) and volumetric methods for assessment of recurrent glioblastoma treated with bevacizumab—a report from the BELOB trial

    Comparison of 2D (RANO) and volumetric methods for assessment of recurrent glioblastoma treated with bevacizumab—a report from the BELOB trial por Renske Gahrmann, Martin J. van den Bent, Bronno van der Holt, René M. Vernhout, Walter Taal, Maaike J. Vos, Jan Cees de Groot, Laurens V. Beerepoot, Jan Buter, Zwenneke Flach, Monique C.J. Hanse, Bas Jasperse, Marion Smits

    Publicado 2017
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  7. 7
    LB-05PHASE III TRIAL EXPLORING THE COMBINATION OF BEVACIZUMAB AND LOMUSTINE IN PATIENTS WITH FIRST RECURRENCE OF A GLIOBLASTOMA: THE EORTC 26101 TRIAL

    LB-05PHASE III TRIAL EXPLORING THE COMBINATION OF BEVACIZUMAB AND LOMUSTINE IN PATIENTS WITH FIRST RECURRENCE OF A GLIOBLASTOMA: THE EORTC 26101 TRIAL por Wolfgang Wick, Aa Brandes, Thierry Gorlia, Martin Bendszus, Felix Sahm, Walter Taal, Martin Taphoorn, Julien Dômont, Ahmed Idbaïh, Mario Campone, Paul M. Clément, Roger Stupp, Michel Fabbro, F Dubois, Carlos Bais, Davide Musmeci, Michael Platten, Michael Weller, V. Golfinopoulos, Martin J. van den Bent

    Publicado 2015
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  8. 8
    Lomustine and Bevacizumab in Progressive Glioblastoma

    Lomustine and Bevacizumab in Progressive Glioblastoma por Wolfgang Wick, Thierry Gorlia, Martin Bendszus, Martin Taphoorn, Felix Sahm, Inga Harting, Alba A. Brandes, Walter Taal, Julien Dômont, Ahmed Idbaïh, Mario Campone, Paul M. Clément, Roger Stupp, Michel Fabbro, Émilie Le Rhun, François Dubois, Michael Weller, Andreas von Deimling, Vassilis Golfinopoulos, Jacoline C. Bromberg, Michael Platten, Martin Klein, Martin J. van den Bent

    Publicado 2017
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  9. 9
    First-line temozolomide chemotherapy in progressive low-grade astrocytomas after radiotherapy: molecular characteristics in relation to response

    First-line temozolomide chemotherapy in progressive low-grade astrocytomas after radiotherapy: molecular characteristics in relation to response por Walter Taal, Hendrikus J. Dubbink, C. B. L. Zonnenberg, Bernard A. Zonnenberg, Tjeerd J. Postma, Johanna M. M. Gijtenbeek, Willem Boogerd, Floris H. Groenendijk, Johan M. Kros, Mathilde C.M. Kouwenhoven, Ronald van Marion, Irene van Heuvel, Bronno van der Holt, Jacoline E. C. Bromberg, Peter A.E. Sillevis Smitt, Winand N.M. Dinjens, Martin J. van den Bent

    Publicado 2010
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  10. 10
    Identification of Patients with Recurrent Glioblastoma Who May Benefit from Combined Bevacizumab and CCNU Therapy: A Report from the BELOB Trial

    Identification of Patients with Recurrent Glioblastoma Who May Benefit from Combined Bevacizumab and CCNU Therapy: A Report from the BELOB Trial por Lale Erdem‐Eraslan, Martin J. van den Bent, Youri Hoogstrate, Hina Naz-Khan, Andrew Stubbs, Peter J. van der Spek, René Böttcher, Ya Gao, Maurice de Wit, Walter Taal, Hendrika M. Oosterkamp, Annemiek Walenkamp, Laurens V. Beerepoot, Monique C.J. Hanse, Jan Buter, Aafke H. Honkoop, Bronno van der Holt, René M. Vernhout, Peter A.E. Sillevis Smitt, Johan M. Kros, Pim J. French

    Publicado 2016
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  11. 11
    ERN GENTURIS tumour surveillance guidelines for individuals with neurofibromatosis type 1

    ERN GENTURIS tumour surveillance guidelines for individuals with neurofibromatosis type 1 por Charlotte Carton, D. Gareth Evans, Ignacio Blanco, Reinhard E. Friedrich, Rosalie E. Ferner, Said Farschtschi, Héctor Salvador, Amedeo A. Azizi, Victor Mautner, Claas Röhl, Sirkku Peltonen, Stavros Stivaros, Eric Legius, Rianne Oostenbrink, Joan Brunet, Frank Van Calenbergh, Cathérine Cassiman, Thomas Czech, María José Gavarrete de León, Henk Giele, Susie M.D. Henley, Conxi Lázaro, Vera Lipkovskaya, Eamonn R. Maher, Vanessa Martín, I.M.J. Mathijssen, Enrico Opocher, Ana Elisabete Pires, Thomas Pletschko, Eirene Poupaki, Vita Ridola, André B. Rietman, Thorsten Rosenbaum, Alastair Santhouse, Astrid Sehested, Ian Simmons, Walter Taal, Anja Wagner

    Publicado 2023
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  12. 12
    Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study

    Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, rando... por Martin J. van den Bent, Brigitta G. Baumert, Sara Erridge, Michael A. Vogelbaum, Anna K. Nowak, Marc Sanson, Alba A. Brandes, Paul M. Clément, Jean Français Baurain, Warren Mason, Helen Wheeler, Olivier Chinot, Sanjeev Gill, Matthew Griffin, David Brachman, Walter Taal, Roberta Rudà, Michael Weller, Catherine McBain, Jaap C. Reijneveld, Roelien H. Enting, Damien C. Weber, Thierry Lesimple, Susan Clenton, Anja Gijtenbeek, S. Pascoe, Ulrich Herrlinger, Peter Hau, F. Dhermain, Irene van Heuvel, Roger Stupp, Ken Aldape, Robert B. Jenkins, Hendrikus J. Dubbink, Winand N.M. Dinjens, Pieter Wesseling, Sarah Nuyens, Vassilis Golfinopoulos, Thierry Gorlia, Wolfgang Wick, Johan M. Kros

    Publicado 2017
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  13. 13
    Prognostic significance of genome-wide DNA methylation profiles within the randomized, phase 3, EORTC CATNON trial on non-1p/19q deleted anaplastic glioma

    Prognostic significance of genome-wide DNA methylation profiles within the randomized, phase 3, EORTC CATNON trial on non-1p/19q deleted anaplastic glioma por C. Mircea S. Tesileanu, Martin J. van den Bent, Marc Sanson, Wolfgang Wick, Alba A. Brandes, Paul M. Clément, Sara Erridge, Michael A. Vogelbaum, Anna K. Nowak, Jean Français Baurain, W. P. Mason, Helen Wheeler, Olivier Chinot, Sanjeev Gill, Matthew Griffin, Leland Rogers, Walter Taal, Roberta Rudà, Michael Weller, Catherine McBain, Myra E. van Linde, Thaís S. Sabedot, Youri Hoogstrate, Andreas von Deimling, Iris de Heer, Wilfred F. J. van IJcken, Rutger W. W. Brouwer, Kenneth Aldape, Robert B. Jenkins, Hendrikus J. Dubbink, Johan M. Kros, Pieter Wesseling, Kin Jip Cheung, Vassilis Golfinopoulos, Brigitta G. Baumert, Thierry Gorlia, Houtan Noushmehr, Pim J. French

    Publicado 2021
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  14. 14
    Adjuvant and concurrent temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): second interim analysis of a randomised, open-label, phase 3 study

    Adjuvant and concurrent temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): second interim analysis of a randomised, open-label, phase 3 stu... por Martin J. van den Bent, C. Mircea S. Tesileanu, Wolfgang Wick, Marc Sanson, Alba A. Brandes, Paul M. Clément, S. C. Erridge, Michael A. Vogelbaum, Anna K. Nowak, Jean Français Baurain, Warren Mason, Helen Wheeler, Olivier Chinot, Sanjeev Gill, Matthew Griffin, Leland Rogers, Walter Taal, Roberta Rudà, Michael Weller, Catherine McBain, Jaap C. Reijneveld, Roelien H. Enting, Francesca Caparrotti, Thierry Lesimple, Susan Clenton, Anja Gijtenbeek, Elizabeth Lim, Ulrich Herrlinger, Peter Hau, F. Dhermain, Iris de Heer, Kenneth Aldape, Robert B. Jenkins, Hendrikus J. Dubbink, Johan M. Kros, Pieter Wesseling, Sarah Nuyens, Vassilis Golfinopoulos, Thierry Gorlia, Pim J. French, Brigitta G. Baumert

    Publicado 2021
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  15. 15
    Temozolomide and Radiotherapy versus Radiotherapy Alone in Patients with Glioblastoma, <i>IDH</i>-wildtype: <i>Post Hoc</i> Analysis of the EORTC Randomized Phase III CATNON Trial

    Temozolomide and Radiotherapy versus Radiotherapy Alone in Patients with Glioblastoma, <i>IDH</i>-wildtype: <i>Post Hoc</i> Analysis of the EORTC Randomized Phase III CATNON Trial por C. Mircea S. Tesileanu, Marc Sanson, Wolfgang Wick, Alba A. Brandes, Paul M. Clément, Sara Erridge, Michael A. Vogelbaum, Anna K. Nowak, Jean‐François Baurain, Warren Mason, Helen Wheeler, Olivier Chinot, Sanjeev Gill, Matthew Griffin, Leland Rogers, Walter Taal, Roberta Rudà, Michael Weller, Catherine McBain, Myra E. van Linde, Kenneth Aldape, Robert B. Jenkins, Johan M. Kros, Pieter Wesseling, Andreas von Deimling, Youri Hoogstrate, Iris de Heer, Peggy N. Atmodimedjo, Hendrikus J. Dubbink, Rutger W. W. Brouwer, Wilfred F. J. van IJcken, Kin Jip Cheung, Vassilis Golfinopoulos, Brigitta G. Baumert, Thierry Gorlia, Pim J. French, Martin J. van den Bent

    Publicado 2022
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  16. 16
    Non-IDH1-R132H IDH1/2 mutations are associated with increased DNA methylation and improved survival in astrocytomas, compared to IDH1-R132H mutations

    Non-IDH1-R132H IDH1/2 mutations are associated with increased DNA methylation and improved survival in astrocytomas, compared to IDH1-R132H mutations por C. Mircea S. Tesileanu, Wies Vallentgoed, Marc Sanson, Walter Taal, Paul M. Clément, Wolfgang Wick, Alba A. Brandes, Jean Français Baurain, Olivier Chinot, Helen Wheeler, Sanjeev Gill, Matthew Griffin, Leland Rogers, Roberta Rudà, Michael Weller, Catherine McBain, Jaap C. Reijneveld, Roelien H. Enting, Francesca Caparrotti, Thierry Lesimple, Susan Clenton, Anja Gijtenbeek, Elizabeth Lim, Filip De Vos, Paul Mulholland, Martin Taphoorn, Iris de Heer, Youri Hoogstrate, Maurice de Wit, Lorenzo Boggiani, Sanne Venneker, Jan Oosting, Judith V.M.G. Bovée, Sara Erridge, Michael A. Vogelbaum, Anna K. Nowak, Warren Mason, Johan M. Kros, Pieter Wesseling, Ken Aldape, Robert B. Jenkins, Hendrikus J. Dubbink, Brigitta G. Baumert, Vassilis Golfinopoulos, Thierry Gorlia, Martin J. van den Bent, Pim J. French

    Publicado 2021
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:

Ferramentas de procura: